Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Motore** is an oral Brazilian prescription herbal medicine developed and manufactured by Aché. It contains a specialized dry extract of *Curcuma longa* rhizome complexed with phosphatidylcholine, providing curcuminoids including curcumin. It is indicated as adjunctive treatment for osteoarthritis and has anti-inflammatory activity; its official product information states that curcuminoids inhibit molecular mediators of pain and inflammation. Motore has been evaluated against ibuprofen in a completed randomized phase IV study in adults with knee osteoarthritis. ([ache.com.br](https://www.ache.com.br/wp-content/uploads/Motore-250-capsulas-BU10_VPS-1.pdf))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Motore.